Proteolytic processing of the nonstructural proteins of the hepatitis C virus (HCV) is mediated by two viral proteinases: the NS2-3 proteinase cleaving at the NS2/3 junction and the NS3 serine-type proteinase responsible for processing at the NS3/4A, NS4A/B, NS4B/5A, and NS5A/B sites. Activity of the NS3 proteinase is modulated by NS4A. In the absence of this cofactor processing at the NS3-dependent sites does not occur or, in the case of the NS5A/B junction, is poor but increased when NS4A is present. Although recent studies demonstrated that proteinase activation requires direct interaction between NS3 and NS4A, the mechanism by which NS4A exerts the activation function is not known. To further analyze the conditions of proteinase activation and to characterize the NS3 sequences important for complex formation and activation we used an in vitro assay in which radiolabeled HCV substrates were mixed with NS3 proteinase and synthetic NS4A peptides. We found that microsomal membranes are not required for proteinase activation. However, they are important for efficient accessibility of the NS4A/B site but not the other trans-cleavage sites. Studies with NS3 deletion mutants identified a region between amino acids 15 and 22 which is essential for proteinase activation. Results obtained with several mutations introduced into this sequence show that a weak overall association between NS3 and NS4A is sufficient for proteinase activation and suggest that a beta-sheet at the NS3 amino terminus plays an important role. Although not essential for proteinase activation the amino terminal 14 NS3 residues were found to have an auxilliary function probably by stabilizing the NS3/4A interaction. Finally, we could demonstrate intracellular, peptide-mediated modulation of proteinase activity providing the basis for the development of a novel therapeutic concept. ᭧
INTRODUCTION
NS5A, and NS5B is mediated by two virally encoded enzymes: The NS2-3 proteinase, a zinc-dependent metalHepatitis C virus (HCV) causes the vast majority of loproteinase cleaving between NS2 and NS3 (Grakoui et transfusion-associated cases of hepatitis and accounts al., 1993a; Hijikata et al., 1993a; Hirowatari et al., 1993) , for a significant proportion of community-acquired hepaand a serine-type proteinase located in the amino termititis cases worldwide (for a review see Cuthbert, 1994) .
nal 180 amino acids of NS3 which is essential for cleavMost, if not all, infections become chronic and in about ing at all the other sites (Bartenschlager et al., 1993 ; 50% of cases result in chronic active hepatitis which Eckart et al., 1993; Grakoui et al., 1993b; Hijikata et al. , may lead after several years to the development of liver 1993a; Manabe et al., 1994; Tomei et al., 1993) . Procirrhosis or hepatocellular carcinoma (for reviews see cessing between NS3 and NS4A is mediated by an intra- Cuthbert, 1994; McDonnell and Lucey, 1995) . molecular reaction, whereas cleavage at the other sites The genomic RNA of HCV contains a single long open can be mediated in trans (Tomei et al., 1993 ; Barreading frame encoding a polyprotein of about 3010 tenschlager et al., 1994; Lin et al., 1994b) . Although enzyamino acids (reviewed by Matsuura and Miyamura, matically active on its own, NS4A, a 54 amino acids long 1993). Numerous studies have shown that this polyprohydrophobic peptide is essential as a proteinase cofactor tein is cleaved co-and posttranslationally into mature (Bartenschlager et al., 1994; Failla et al., 1994; Lin et al., viral proteins . Processing of the structural proteins lo1994b) . While cleavage at the NS3/4A, NS4A/B, and cated in the amino terminal quarter of the polyprotein is NS4B/5A junctions is absolutely dependent on NS4A, mediated by host cell signalases cleaving in the lumen processing between NS5A and NS5B can be mediated of the endoplasmic reticulum and generating the putative by NS3 alone but at least for some HCV isolates is greatly nucleocapsid protein (core) and the envelope glycoproincreased by the NS4A cofactor. Several studies have teins E1 and E2 (Hijikata et al., 1991; Santolini et al., demonstrated formation of a stable NS3/4A complex 1994; Lin et al., 1994a; Mizushima et al., 1994) . Maturation (Bartenschlager et al., 1995a; Failla et al., 1995; , of the nonstructural proteins NS2, NS3, NS4A, NS4B, 1995a; . Mutational ablation of complex formation also impairs cleavage at the NS4A-dependent sites, suggesting that proteinase activation is achieved protein) or in trans (when expressed as part of the subPlasmid constructions strate or as a separate molecule). Deletion studies have
The basic vector pTM1-2 and constructs pTM1712-shown that the central NS4A domain is essential for pro-3011, pTM1007-1711, pTM1659-1711, pTM1027-1238, teinase activation and were extended by several mutapTM1034-1238, pTM1041-1238, and pTM1049-1238 have tion analyses identifying within this domain residues parbeen described recently (Bartenschlager et al., 1995a ; ticularly important for the activation function (Bar- Fig. 1 ). tenschlager et Lin et al., 1995a; Standard recombinant DNA techniques were used for 1995; Shimizu et al., 1996) . With respect to the NS3 proconstruction of all plasmids (Sambrook et al., 1989) . Plastein recent reports have shown that sequences at the mids pTM1007-1657 and pTM1007-1657/3A were ob-tained amino terminus are involved in complex formation and by insertion of SalI-SpeI fragments from pATA1007-1658 proteinase activation function but left open a more deor pATA1007-1658/SúA, respectively (Bartenschlager et tailed characterization of the residues required (Baral., 1994) , into the SalI/SpeI-digested pTM1007-3011 (Bartenschlager et al., 1994; Failla et al., 1995; Satoh et al., tenschlager et al., 1995a ). pTM1659-1972 was constructed 1995 .
by inserting the HCV fragment obtained by PCR via the Using an in vitro system essentially as described by introduced NcoI and SpeI restriction sites into pTM1-2. Lin and coworkers (1995a) , which is based on the mixing Plasmid pTM2337-2516 was obtained in the analogous of in vitro-translated radiolabeled HCV-substrates, in way using oligonucleotides complementary to sequences vitro-translated proteinase, and NS4A-specific synthetic within NS5A or NS5B. To construct plasmid pTM1712-peptides, we studied the mechanism and conditions of 2419/P1F carrying a phenylalanine substitution at the P1 proteinase activation and performed a detailed analysis position of the 4B/5A site a PstI-EcoRI fragment isolated of the NS3 sequences involved in activation by the NS4A from pATA4B-5A/P1-C r F (Bartenschlager et al., 1995b) cofactor.
was inserted into pTM1712-2419. Site-directed mutagenesis was done by PCR methodology according to the proto-MATERIALS AND METHODS col of Stappert et al. (1992) . In brief, for one mutagenesis a phosphorylated oligonucleotide introducing the desired Cells and viruses substitution and a ''tagged'' oligonucleotide complementary Cell monolayers of the BHK-21, human TK 0 143 and to the encephalomyocarditis virus sequence (EMCV, ElroyHeLa cell lines were grown in Dulbecco's modified mini- Stein et al., 1989) upstream of the HCV insert were hybridmal essential medium (DMEM) supplemented with 2 mM ized to the denatured DNA. The sequence of the tagged L-glutamine, nonessential amino acids, 100 U penicillin primer is ACTGATCAAGCAGTATGTACTACGAACGTCper milliliter, 100 mg streptomycin per milliliter, and 10%
TAGGCCC-CCCGAACCA (EMCV-specific sequence in fetal calf serum (FCS). The recombinant vaccinia virus bold letters; tag sequence underlined). After treatment with vTF7-3 expressing the RNA polymerase of bacteriophage T4 DNA polymerase and T4 DNA ligase (Biolabs, Bad T7 has been described recently (Fuerst et al., 1986) .
Schwalbach/Taunus, Germany) unincorporated oligonucleStocks of recombinant vaccinia viruses were grown in otides were removed using a spin column (Quiagen, Hilden, TK 0 143 cell monolayers and titers of infectious progeny Germany) according to the instruction of the manufacturer were determined by plaque assay using the same cell and one-tenth of the eluate was used for a PCR with an line. Homologous recombination into the vaccinia virus oligonucleotide identical to the tag-sequence and an HCVgenome was done exactly as described recently (Barspecific antisense primer. Purified fragments were retenschlager et al., 1994) . stricted with NcoI and SfiI and inserted into pTM1027-1238. All transferred fragments were verified by DNA sePeptides and antisera quence analysis.
Peptides were synthesized by the procedure of Fmoc In vitro transcription and translation chemistry (Atherton et al., 1988) . After cleavage from the resin peptides were purified by preparative reverse Plasmid DNAs purified by CsCl density gradient centrifugation were linearized downstream of the HCV insert. phase high performance liquid chromatography (RP-HPLC). The homogeneity of the purified peptides as conIn case of the NS4B-5A 148 and the NS4B-5A 148 /P1F substrates, plasmids pTM1712-3011 and pTM1712-2419/P1F firmed by analytical RP-HPLC was greater than 95% and the molecular weight was determined by ion spray-mass were restricted within NS5A, respectively. After phenol/ chloroform extraction and ethanol precipitation DNAs spectrometry. Peptides were dissolved in water or, in case of pep4A [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] proteins an amino acid mixture lacking methionine and for cell lysis and immunoprecipitation (Bartenschlager et al., 1995a) . supplemented with protein labeling mixture (Translabel; ICN, Meckenheim, Germany) at a final concentration of 800 mCi/ml was added to the lysate. To produce nonradi-RESULTS oactive proteinases translations were performed with Establishment of an in vitro trans-cleavage assay mixtures containing all amino acids. For some translations 1 ml of canine pancreatic microsomal membranes
To characterize the mechanism of NS3 proteinase activation in more detail we devised an in vitro trans-cleav-(Boehringer Mannheim, Germany) was added to a 25-ml in vitro translation reaction. age assay essentially as described recently (Lin et al., 1995a) . A radiolabeled HCV polyprotein fragment spanning the NS4B/5A junction (4B-5A 148 ; Fig. 1 ) and a nonraIn vitro processing assay diolabeled NS3 proteinase were generated by separate in vitro translation reactions and equal amounts of the After 1 hr at 30Њ reactions were terminated by the addition of cycloheximide and RNaseA to final concenrespective lysates were mixed as described under Matetrations of 300 and 10 mg/ml, respectively, followed by 10 min incubation at room temperature. Equal amounts of proteinase and substrate containing lysates were mixed and peptide was added to final concentrations specified in the figure legends. After 120 min at 30Њ reactions were stopped by the addition of protein sample buffer (200 mM Tris -HCl, pH 8.0, 5 mM EDTA, 3.3% sodium dodecyl sulfate (SDS), 2% 2-mercaptoethanol, 10% sucrose, and 0.1% bromophenol blue) and proteins contained in the reaction mixtures were analyzed by Tricine -SDS -polyacrylamide gel electrophoresis (PAGE) or SDS -12.5% PAGE and fluorography. To determine the peptide concentrations required for maximal proteinase activation various amounts of a peptide (1 -100 mM) were added into a series of cleavage reactions with the NS4B/5A 148 substrate and the reaction with the highest amount of NS4B was determined after SDS -PAGE and fluorography.
Trans-processing assay in tissue culture
HeLa cells were infected with virus mixtures (vTF7-3 and one or two HCV-recombinant vaccinia viruses) each at a multiplicity of infection of 4 for 1 hr. After removal of the inoculum cells were incubated for 2 hr in DMEM containing 10% FCS at 37Њ. Cells were washed twice in FCS-free DMEM followed by the addition of methionine- ase complex was done as described recently using NPB NS3 PROTEINASE ACTIVATION BY NS4A PEPTIDES of the cleavage reaction was shown by absence of NS4B in the reactions in which (i) no NS4A peptide was added rials and Methods. Synthetic NS4A peptides were added (lane 2), (ii) an enzymatically inactive NS3 proteinase was and proteinase activation was determined by comparing used (NS3/3A; lane 9), and (iii) an NS4B-5A 148 substrate the amounts of NS4B produced by cleavage with the was used in which the P1 cysteine residue of the cleavparental proteinase with the amounts of NS4B obtained age site was substituted by a phenylalanine rendering by processing with one of the altered enzymes. Expresthis site resistant to NS3-mediated cleavage (lane 12; sion levels and stabilities of proteinase RNAs were deter- Bartenschlager et al., 1995b) . This latter result also sugmined by in vitro translations in the presence of protein gested that processing in the system described here labeling mixture using the same RNA preparation taken occurred at the same position identified by sequence to generate the nonradiolabeled enzymes.
analysis of NS4B generated by intracellular cleavage at To identify the NS4A region required for optimal prothe NS4B/5A site (Grakoui et al., 1993b) . Although we teinase activation in this in vitro system we used a panel cannot rule out the possibility that lack of activation by pep4A 22-29 was due to the foreign carboxy terminal seof different peptides. As specified in Table 1 , to increase quence, in summary, the results show that the minimal activation domain as determined in this in vitro assay maps between amino acid 18-22 at the amino terminus and 29-34 at the carboxy terminus of the cofactor.
In the experiment shown in Fig. 2 we used 10 mM peptide as a starting concentration. To determine the optimal concentration for each peptide more precisely and to analyze whether the shorter peptides could at least partially activate the proteinase when used at higher concentrations each peptide was titrated in this assay. As summarized in Table 1 the lowest concentration was required in the case of the longest peptide with increasing concentrations being necessary for the shorter peptides to achieve the same cleavage efficiency (pep4A 18-38 and pep4A [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] ). Interestingly, the amounts of NS4B obtained with the activating peptides were about the same at the optimal peptide concentrations. No activation was observed in the case of pep4A 18-29 , pep4A [22] [23] [24] [25] [26] [27] [28] [29] , and pep4A 38-54 even when concentrations up to 100 mM were used in the trans-cleavage assay. Thus, although pep4A 17-34 still could activate the proteinase, amino terminal NS4A sequences clearly increased the activation function. For this reason in all subsequent experiments we used pep4A 4-35 at a final concentration of 10 mM.
Microsomal membranes are not essential for processing at the NS4B/5A and NS5A/B sites but are important to render the NS4A/B site accessible for cleavage Given that NS4A is a hydrophobic, membrane-associated protein and that the same probably holds true at least for some of the other nonstructural proteins (Hijikata et al., 1993b; Selby et al., 1993; , we analyzed a possible influence of microsomal membranes on proteinase activation and cleavage efficiency at any of the trans-processing sites. To examine a potential effect of membranes on the substrate, polyprotein fragments bearing the NS4A/B, NS4B/5A, or NS5A/B junctions were generated by in vitro translations in the absence or presence of canine pancreatic microsomal reaction with peptide, suggesting that in the case of the membrane-free NS4A/B substrate the scissile bond was only poorly accessible for the proteinase (lane 3). Effi-NS5A/B site in the absence of peptide which was greatly increased when pep4A 4 -35 was added (Fig. 3C , cient processing, largely independent from peptide was observed with the NS4A/B translated in the presence of compare lanes 2 and 3; Failla et al., 1994; Bartenschlager et al., 1995a) . Processing at this site also membranes demonstrating NS3 activation by substratederived NS4A (lane 5, 6). In contrast, in the case of was not affected by microsomal membranes (compare lane 3 with lane 6). the 4B-5A 148 substrate cleavage was independent from microsomal membranes (Fig. 3B, compare lanes 3 and
In the experiment described so far we characterized the effect of membranes on the cleavability of the various 6). In agreement with results from cell culture experiments a low but significant cleavage was found at the trans-processing sites. To analyze whether membranes tenschlager et al., 1994; Failla et al., 1995; Satoh et al., 1995) . To analyze whether the same could be found in this in vitro trans-cleavage system three amino terminal truncations were tested in parallel with the parental NS3 1 -211 and an enzymatically inactive proteinase (NS3 1 -211 /3A). To simplify all subsequent cloning steps these deletions were introduced into a truncated NS3 sufficient for full proteolytic activity (amino acids 1-211; Bartenschlager et al., 1994) . If corrected for different expression levels of proteinases, no difference with respect to peptide-activated cleavage at the NS4B/5A site was found between the parental proteinase or an NS3 lacking 7 or 14 amino terminal residues (Fig. 5A, lane 2, 4, 5) . Removal of 22 amino acids led to an enzyme which no longer could be activated but still had retained its enzymatic activity as determined by 4A-independent processing between NS5A and NS5B (data not shown). This result demonstrates that the 14 amino terminal residues exert a direct effect on the activation function of the cofactor, NS4A was generated by in vitro translation in the presence or absence of microsomal membranes and used to activate NS3 cleavage at the NS4B/5A site. As shown in Fig. 4A , NS4B was readily detected in the reaction using membrane-free NS4A but the signal was significantly lower compared to the reaction with NS4A translated in the presence of membranes (compare lane 5 with lane 6). However, analysis of the control translations revealed higher amounts of NS4A translated in the presence of membranes, suggesting that the observed increase of processing efficiency at least in part is due to higher amounts of NS4A in the corresponding cleavage reaction and not to higher activation function (Fig. 4B,  lanes 2 and 3) . Furthermore, cleavage efficiency obtained with pep4A was not increased by preincubation of the peptide with membranes (compare lane 3 with lane 4). From these results we conclude that (i) the NS4A-activation function essentially is independent from membranes, (ii) membranes most likely are important for proper folding of the NS4A-B substrate to render the cleavage site accessible to the proteinase, and (iii) membranes are dispensable for processing at the NS4B/5A and NS5A/B junctions. Kyte and Doolittle (1982) with a window of 6 amino acids is shown in the top. The sequence having a high probability to form a beta-sheet structure according to the algorithm of Chou and Fasman (1978) is indicated above. An alignment of the NS3 sequence of our isolate (HCV-G01) with the sequences of HCV-isolates given on the left is drawn below the hydrophobicity profile. The region essential for proteinase activation is marked by the box. Amino acids selected for mutation analysis are indicated by arrows pointing to the substituting residues. HCV isolates are described in the following references: HCV-1 (Choo et al., 1991); HCV-H (Inchauspe et al., 1991) ; HCV-BK (Takamizawa et al., 1991) ; HCV-J (Kato et al., 1990) ; HCV-T (Chen et al., 1992) . bicity analyses identified several features which might residue and the reduction of the activation. As exemplified for the exchanges of the serine residue at position be important for interaction with NS4A: (i) a potential beta-sheet structure between residues 5 and 22 and (ii) 20 substitution by valine predicted not to interfere with a beta-sheet structure had no effect on peptide-mediated a hydrophobicity profile characterized by a sequence of hydrophilic, hydrophobic, and, again, hydrophilic resiactivation. In contrast, substitutions by proline or glutamic acid severely reduced or completely blocked cleavdues. To experimentally evaluate the possible importance of these motifs for proteinase activation a mutation age (lanes 14 and 15). Principally the same was observed for the other mutations between positions 17 and 22 analysis was performed. Focussing primarily on the important sequence between residues 15 and 22, three since, also in these cases, substitutions by acidic amino acids or proline reduced cleavage significantly while different types of substituting residues were selected: (i) hydrophobic amino acids likely to preserve a beta-sheet substitutions by hydrophobic residues had no or, in the case of the threonine exchange by phenylalanine at posistructure (V, F, or I), (ii) proline, known to disturb ordered protein structure, and (iii) negatively charged amino acids tion 19, a moderate effect. Mutations carboxy terminal of the essential domain also affected cleavage. While less favorable for the formation of a beta-sheet (D or E). The substitutions were introduced into the NS3 1 -211 substitutions by valine at position 24 and 26 were well tolerated, substitutions by proline and valine at position proteinase and tested for peptide-mediated cleavage at the NS4B/5A site as described above. As expected muta-23 and 25, respectively, significantly reduced cleavage, suggesting that sequences carboxy terminal of the minitions amino terminal to the essential activation domain did not or only moderately reduce proteinase activation mal domain, as defined by the deletion study, also play an important role for proteinase activation. (Fig. 7A, lane 4-6 ). More drastic effects were observed in the case of mutations within the essential domain So far we only used single amino acid exchanges and observed a remarkable tolerance of the NS3 proteinase with a clear parallel between the kind of the substituting Table 2. for mutations in the amino terminal region involved in interaction with NS4A, strengthening the assumption that proteinase modulation is achieved via direct interaction peptide-mediated activation (summarized in Table 2 ). To extend this observation two or three residues were subwith the cofactor (for a summary of all mutants see Table  2 ). However, in some cases coprecipitation was reduced stituted simultaneously and the mutants were tested with the same trans-cleavage assay. The inhibitory effect obalthough no effect was found in terms of proteinase activation (e.g., the isoleucine substitution at position 10; Fig.  served for substitutions by proline was additive because introduction of two proline residues led to enzymes 8, lanes 3 and 4). This discrepancy has to be ascribed to the fact that for technical reasons, coprecipitation apwhich could no longer be activated (double mutation (DM) 2 and 3, lanes 23 and 24). In contrast, introduction parently is more sensitive toward substitutions than NS4A-dependent cleavage at the NS4B/5A site (Barof two or even three exchanges by hydrophobic amino acids tolerated as single substitutions had no significant tenschlager et al., 1995a) . In summary, the finding that even simultaneous mutations at several positions within effect (DM-1 and triple mutation (TM), lanes 22 and 25, respectively). the NS3 amino terminus have no effect on activation and the high tolerance for substitutions described for the Proteinase activation most likely is mediated via direct interaction with NS4A. Therefore we analyzed the effects central NS4A domain (Bartenschlager et al., 1995a; Lin et al., 1995a; Shimizu et al., 1996) show that a weak of the amino terminal substitutions on complex formation. Since this property could not be examined in the transoverall interaction is sufficient for proteinase activation and suggest the existence of multiple interaction sites cleavage system described so far we used coimmunoprecipitation of NS3 and NS4A coexpressed in cell culbetween the proteinase and its cofactor. Furthermore, as deduced from the correlation between the nature of the ture with the vaccinia virus T7-system ( Fig. 8 ; Bartenschlager et al., 1995a) . The NS4A-construct was substituting residue and the influence on the activation structural integrity of the NS3 amino terminus probably transfected together with one of the various NS3 mutations into BHK-21 cells previously infected with a recomforming a beta-sheet structure is important for NS4A-mediated activation. binant vaccinia virus directing the expression of the RNA polymerase from bacteriophage T7 (Fuerst et al., 1986) . After metabolic radiolabeling, NS3 and NS4A were isoAccessory function of the NS3 sequence amino lated from the cell lysate by immunoprecipitation under terminal of residue 15 nondenaturing conditions. As controls transfections of the parental proteinase alone or together with NS4A
As described above, the amino terminal 14 residues of NS3 can be removed without affecting proteinase actiwere performed in parallel (lane 43-46). In all cases mutations affecting proteinase activation also affected vation. On the other hand, NS3 enzymes lacking the first still cleave at the NS5A/B junction in the absence of NS4A showing that the exchanges had not destroyed amount of NS5A produced during the 4-hr labeling period. As control a coexpression of substrate with the a pep4A 4-35 mediated activation (Fig. 7) . Mean values from three independent experiments. //, amount of NS4B comparable to the amount proteinase and NS4A 2-54 was included. As shown in Fig. obtained with the unaltered proteinase; /, õ50% reduction of NS4B; 10 (middle panel), low but significant amounts of NS5A {, ú50% reduction; 0, no NS4B detectable.
were found in cells incubated with 50 mM peptide (lane b Interaction between NS3 1 -211 and NS4A 2-54 (Fig. 8) . /, comparable 3). Proteinase activation was more efficient when higher to wild type; {, ú50% reduction; 0, no coprecipitation.
concentrations of peptide were added but slightly rec n.a., not applicable since proteinase could not be detected by immunoprecipitation.
duced the overall expression most likely due to cellular toxicity (lanes 1 and 2). Although efficiency of proteinase activation was much lower compared to the in vitro sys-7 or 14 amino acids form successively less stable comtem or to activation by coexpressed NS4A 2-54 (probably plexes with NS4A (Bartenschlager et al., 1995a; due to poor uptake or low stability of the peptide) this et al., 1995) . Assuming that this region would have an result demonstrates that the NS3 proteinase can be modaccessory function by stabilizing the complex we exulated by a synthetic peptide also intracellularly. pected that substitutions which only have a moderate effect on proteinase activation would be deleterious if DISCUSSION introduced into an NS3 lacking amino terminal sequences. To experimentally test this assumption we seIn this report a cell-free trans-processing assay system essentially as described by Lin and coworkers (1995a) lected two single substitutions with a moderate effect on proteinase activation (19 T r E and 22 T r P) and a was used to study conditions required for proteinase activation and to characterize NS3 sequences involved substitution without effect (20 S r V). The corresponding exchanges were introduced into NS3 in activation by the NS4A cofactor.
In agreement with recent reports we found that the cenand compared with the parental NS3 1 -211 substitutions. If corrected for the amounts of proteinase translated from tral NS4A region is sufficient to activate the proteinase (Bartenschlager et al., 1995a; Lin et al., 1995a ; Tanji et the individual RNAs, no effect was found for the valine substitution at position 20 (Fig. 9A, lanes 8-10) . Shimizu et al., 1996) . However, since a lower concentration of the aminoterminally extended peptide case of the glutamic acid substitution at position 19, removal of 7 or 14 amino terminal residues reduced or (pep4A 4-35 ) was required for NS3 activation sequences at the amino terminus of NS4A obviously improve the activablocked cleavage, respectively (lanes 5-7). The most pronounced effect was found for the proline substitution tion function, most likely by stabilizing the NS3/4A interaction (Bartenschlager et al., 1995a; Lin et al., 1995a) . at position 22. In this case removal of the first 7 amino acids was sufficient to block peptide-mediated activation
As described by us and two other groups, sequences at the extreme amino terminus of NS3 are not essential (lane 12). It should be noted that all proteinases could FIG. 8 . Substitutions in the amino terminal NS3 region and their effects on complex formation with NS4A. BHK-21 cells infected with the recombinant vaccinia virus vTF7-3 were transfected with pTM1659-1711 (NS4A 2 -54 ) and one of the various proteinase constructs. As control transfections with the parental proteinase construct alone or together with the NS4A plasmid were performed in parallel (lanes 43 -46). HCVspecific proteins were isolated from the cell lysate by immunoprecipitation under nondenaturing conditions and separated by Tricine -SDS -11% PAGE. Note that the proteinase 20S r E could not be detected by this procedure and therefore is not included in the figure. For a summary of the results see Table 2. for proteinase activation but important for stabilization of action with the cofactor (Bartenschlager et al., 1995a; Failla et al., 1995; Satoh et al., 1995) . However, it should the complex (Bartenschlager et al., 1995a; Failla et al., 1995; Satoh et al., 1995) . As also shown now for this in be noted that under certain experimental conditions a proteinase lacking 28 amino terminal residues still can vitro system, the first 14 residues can be removed without significantly affecting cleavage at the NS4B/5A site, be activated to cleave at the NS4B/5A site in trans (although the level of activation is very low), suggesting that whereas removal of a further 9 amino acids leads to an NS3 which no longer can be activated. This result identisome minor interactions between NS3 and NS4A outside the regions described here is possible or an alternative fies the region between residues 15 and 22 as essential for activation and suggests that sequences amino termiactivation mechanism exists (Failla et al., 1995) . The nature of the interaction between NS3 and NS4A nal to it have an auxiliary function. This conclusion is further supported by the observation that substitutions is less clear. As deduced from secondary structure predictions both the NS3 amino terminus (residues 5-22; within the essential region are deleterious when amino terminal sequences are missing but are tolerated or re- Fig. 6 ) and the central NS4A region have a high probability for the formation of a beta-sheet. At least for NS3 this duce proteinase activation moderately when introduced into an NS3 with an authentic amino terminus. Furtherprediction is supported by our mutation analysis showing that substituting residues likely to preserve this structure more, removal of amino terminal NS3 sequences impairs coprecipitation with NS4A, suggesting that the auxiliary are well tolerated, whereas amino acids disturbing or interfering with a beta-sheet structure are less favorable function of this region is mediated by stabilizing the inter-principally is sufficient, and attachment of NS3 to ER membranes. Given that the carboxy terminal NS3 domain encodes an RNA helicase (Kim et al., 1995) , membrane attachment of NS3 (via NS4A) would primarily be important for the formation of a membrane-associated replicase complex. Possibly in this case requirements for complex formation are different.
Besides direct inhibition of proteinase activity, blocking NS3/4A interaction may be a novel concept for the development of an antiviral therapy. Using an activating NS4A-peptide as a model compound we could show that proteinase activity can be modulated intracellularly. Thus, engineered NS4A-peptides or synthetic compounds dominantly inhibiting the activation function of authentic NS4A (Shimizu et al., 1996) in principle should be usable as therapeutics. However, it should be kept in mind that processing between NS3 and NS4A-probably the first polyprotein cleavage event mediated by NS3-is a rapid intramolecular reaction and most likely is preceeded by a rapid (cotranslational) interaction be- Lin et al., 1994a) . Given this rapid and efficient main. (A) 4B-5A 148 substrate was incubated with lysates containing interaction, inhibition of complex formation may be diffiproteinases specified above each lane in the presence of 10 mM pep4A 4-35 . Proteins were analyzed by SDS-12.5% PAGE as described in the legend to (proline or acidic amino acids, respectively). This structure probably can allow formation of multiple interactions between these two proteins within a relatively short sequence of only about 20 amino acids, thereby explaining the high tolerance of both NS3 and NS4A for substitutions within the activation domains (Bartenschlager et al., 1995a; Lin et al., 1995a; Shimizu et al., 1996) . How NS4A exerts the activation function is not known. One possibility is that upon binding of NS4A conformational changes within NS3 take place making the structure more ideal for substrate binding and/or catalysis. However, besides modulation of proteinase structure, the hydrophobic NS4A is also required for localization of NS3 to membranes of the endoplasmic reticulum (Hijikata et al., 1993b; . In this way NS4A would increase the local concentration of proteinase in close (Selby et al., 1993) and by concentrating NS3 in the expression of the NS4B-5B substrate, the NS3 1 -211 proteinase such a compartment sequester it from rapid degradation (Prot.), or NS4A 2-54 as indicated above the upper panel. Proteins were by cellular enzymes . However, as radiolabeled metabolically for 4 h in the presence of various concentrashown in this study and two other reports (Lin and Rice, tions of pep4A 4-35 as given above the lanes and HCV-specific proteins 1995b; Shimizu et al., 1996) , microsomal membranes are were isolated by immunoprecipitation from the cell lysate using antisera monospecific for NS5B (upper panel), NS5A (middle panel), or not essential for NS4A to exert the activation function, NS3 (lower panel) . Identification of HCV-proteins is given on the left of strongly suggesting that membrane attachment of NS3 each panel. Since immunoprecipitations were performed under nondeand protection from rapid degradation are not the main naturing conditions the appearance of NS4B-5A and NS5B in the immumechanisms of proteinase activation. Rather, interaction noprecipitations with anti-NS5B and anti-NS5A, respectively, is due to between NS3 and NS4A appears to have a dual role:
protein-protein interactions not disrupted under these conditions (upper and middle panel, respectively). activation of NS3, for which a rather weak interaction NS3 PROTEINASE ACTIVATION BY NS4A PEPTIDES are required for proteolytic processing of hepatitis C virus nonstruccult to achieve. Further studies will be required to see tural proteins. J. Virol. 68, [3753] [3754] [3755] [3756] [3757] [3758] [3759] [3760] whether peptides or small compounds can inhibit the Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986 
